3 Results for "

ASTX-660

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "ASTX-660" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-109565
CAS No.: 1799328-86-1
Purity:  99.81%
Synonyms: ASTX660
Target:  

Apoptosis TNF Receptor IAP

Research Areas:  

Cancer

Tolinapant (ASTX660) is an orally active cIAP1/2 and XIAP antagonist, with an IC50 of < 40 nM against XIAP and an IC50 of <12 nM against cIAP1. Tolinapant triggers TNFα-dependent Apoptosis in cancer cells. Tolinapant inhibits tumor growth in mouse xenograft models. Tolinapant can be used in research related to breast cancer, melanoma, lymphoma, multiple myeloma, acute lymphoblastic leukemia and advanced solid tumors .
loading...
    loading...
Cat. No.: HY-109565R
CAS No.: 1799328-86-1
Synonyms: ASTX660 (Standard)
Research Areas:  

Cancer

Tolinapant (Standard) is the analytical standard of Tolinapant (HY-109565). This product is intended for research and analytical applications. Tolinapant (ASTX660) is an orally bioavailable dual antagonist of cellular inhibitor of apoptosis protein (cIAP) and X-linked inhibitor of apoptosis protein (XIAP).
loading...
    loading...
Cat. No.: HY-109565B
CAS No.: 1799328-50-9
Synonyms: ASTX660 dihydrochloride
Target:  

Apoptosis TNF Receptor IAP

Research Areas:  

Cancer

Tolinapant dihydrochloride (ASTX660 dihydrochloride) is an orally active cIAP1/2 and XIAP antagonist, with an IC50 of < 40 nM against XIAP and an IC50 of <12 nM against cIAP1. Tolinapant dihydrochloride triggers TNFα-dependent Apoptosis in cancer cells. Tolinapant dihydrochloride inhibits tumor growth in mouse xenograft models. Tolinapant dihydrochloride can be used in research related to breast cancer, melanoma, lymphoma, multiple myeloma, acute lymphoblastic leukemia and advanced solid tumors .
loading...
    loading...